Use of a plastic endoprosthesis to successfully treat esophageal perforation following radiofrequency ablation of Barrett's esophagus

Endoscopy

Volumn 43, Issue 1, 2011, Pages 67-69

  Vahabzadeh, B ^a   Rastogi, A ^a   Bansal, A ^a   Sharma, P ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ENDOPROSTHESIS; ESOPHAGUS PERFORATION; HUMAN; MALE; PARENTERAL NUTRITION; PNEUMOMEDIASTINUM; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; THORAX RADIOGRAPHY;

BARRETT ESOPHAGUS; CATHETER ABLATION; ESOPHAGEAL PERFORATION; HUMANS; MALE; MIDDLE AGED; PLASTICS; STENTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78651280935     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0030-1256070     Document Type: Article

References (14)

1. Spechler S J. Barrett's esophagus. N Engl J Med 2002 346 836-842
2. Drewitz D J., Sampliner R E., Garewal H S. The incidence of adenocarcinoma in Barrett"s esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997 92 212-215
3. Pohl H, Welch H G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005 97 142-146 (Pubitemid 40277094)
4. Reid B J., Sánchez C A., Blount P L. et al. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993 105 119-129
5. Rastogi A, Puli S, El-Serag H B. et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 2008 67 394-398
6. Sharma P, Falk G W., Weston A P. et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006 4 566-572
7. Swisher S G., Deford L, Merriman K W. et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000 119 1126-1132
8. Shaheen N J., Sharma P, Overholt B F. et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009 360 2277-2288
9. Schembre D B., Huang J L., Lin O S. et al. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest Endosc 2008 67 602-603
10. Sharma P, Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006 131 1392-1399
11. Reid B J., Levine D S., Longton G et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identifying low- and high-risk patient subsets. Am J Gastroenterol 2000 95 1669-1676
12. Pech O, Behrens A, May A et al. Long term results and risk factor analysis for recurrence after curative endoscopic therapies in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008 57 1200-1206
13. US Food and Drug Administration MAUDE database. Available at: http://www.fda.gov/default.htm. MDR report keys 983732 and 95694931. Accessed: August 2009
14. Wang K, Sampliner R. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008 103 788-797